Hiroyuki Ohnuma

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.

Yoshito Itoh, Emiko Takai, Hiroyuki Ohnuma et al. · Proceedings of the National Academy of Sciences · 1986 · 243 citations · Full text

Vaccination, Protective Efficacy, Vaccine Development +14

A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins

A Machida, Seiji Kishimoto, Hiroyuki Ohnuma et al. · Gastroenterology · 1983 · 173 citations

Vaccination, Human Leukocyte Antigen, Viral Hepatitis +8

Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study

Yasushi Sato, Hiroyuki Ohnuma, Takayuki Nobuoka et al. · Gastric Cancer · 2016 · 96 citations · Full text

Surgical Oncology, Conversion Therapy, Gastrointestinal Oncology +9

Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer

Yasushi Sato, Tetsuji Takayama, Tamotsu Sagawa et al. · Cancer Chemotherapy and Pharmacology · 2009 · 81 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +6

Augmentation of antitumor effects of p53 Gene therapy by combination with HDAC inhibitor

Rishu Takimoto, Junji Kato, Takeshi Terui et al. · Cancer Biology & Therapy · 2005 · 66 citations · Full text